Are Wall Street Analysts Bullish on Becton, Dickinson and Company Stock?

With a market capitalization of $48.9 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public worldwide. 

Shares of the company have underperformed in the broader market over the past year and in 2026. BDX stock has declined 25.2% over the past 52 weeks and 11.5% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 14.4% over the past year and risen 1.4% in 2026.